Faeth Therapeutics (FTH) Net Shares Issued and Repurchased (2020 - 2026)

Faeth Therapeutics (FTH) has reported Net Shares Issued and Repurchased for 7 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Shares Issued and Repurchased rose 192.9% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (up 192.9% YoY), and the FY2025 full-year result was $47224.0, down 98.27% from the prior year.
• Net Shares Issued and Repurchased advanced to $2.5 million in Q1 2026 per FTH's latest filing, from $47224.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $2.7 million in Q4 2024 and bottomed at $47224.0 in Q4 2025.
• Historically, Net Shares Issued and Repurchased has averaged $1.2 million across 5 years, with a median of $849500.0 in 2025.
• The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased surged 248.83% in 2024, then plunged 98.27% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.1 million in 2022, then plunged by 31.53% to $783371.0 in 2023, then soared by 248.83% to $2.7 million in 2024, then slumped by 98.27% to $47224.0 in 2025, then surged by 5168.99% to $2.5 million in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $2.5 million, $47224.0, and $849500.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.